Results 271 to 280 of about 205,284 (341)

Impotence after prostatectomy. [PDF]

open access: green, 1990
H W Gilbert, J C Gingell
openalex   +1 more source

Assessing Clinician Consistency in Wound Tissue Classification and the Value of AI‐Assisted Quantification: A Cross‐Sectional Study

open access: yesInternational Wound Journal, Volume 22, Issue 6, June 2025.
ABSTRACT This study investigated the relationship between clinician assessments and the AI‐generated scores, highlighting how correlations vary based on clinician expertise. It also explored the proportion of tissue types identified by clinicians relative to AI assessments and assess the inter‐clinician agreement in quantifying tissue types ...
Heba Talla Mohammed   +7 more
wiley   +1 more source

Does the surgeon's learning curve impact pentafecta outcomes in radical prostatectomy? a systematic review and meta-analysis. [PDF]

open access: yesBMC Urol
Da Cruz JAS   +10 more
europepmc   +1 more source

Discussion on Prostatectomy—Early or Late?

open access: bronze, 1960
Paul Roger, Howard G. Hanley, R I Bodman
openalex   +1 more source

Cardiac stress during transurethral prostatectomy. [PDF]

open access: green, 1992
Pauline M. Dobson   +4 more
openalex   +1 more source

Beyond fluorodeoxyglucose: Molecular imaging of cancer in precision medicine

open access: yesCA: A Cancer Journal for Clinicians, Volume 75, Issue 3, Page 226-242, May/June 2025.
Abstract Cancer molecular imaging is the noninvasive visualization of a process unique to or altered in neoplasia, such as proliferation, glucose metabolism, and receptor expression, which is relevant to patient management. Several molecular imaging modalities are now available, including magnetic resonance, optical, and nuclear imaging.
Malik E. Juweid   +6 more
wiley   +1 more source

Etiology of prostate cancer with the TMPRSS2:ERG fusion: A systematic review of risk factors

open access: yesInternational Journal of Cancer, Volume 156, Issue 10, Page 1898-1908, 15 May 2025.
What's new? The most common somatic alterations in primary prostate cancer are gene fusions involving TMPRSS2 and ERG. TMPRSS2:ERG‐positive cancers may be etiologically distinct from cancers without this fusion. This study sought to better understand etiologic factors underlying TMPRSS2:ERG fusion in prostate cancer via systematic review of ...
Colleen B. McGrath   +10 more
wiley   +1 more source

Home - About - Disclaimer - Privacy